President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
All content for The Commercial Awareness Compass by AllAboutLaw is the property of AllAboutLaw and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
Hiring under pressure: the reform that could rewrite recruitment | Commercial Awareness Compass #46
The Commercial Awareness Compass by AllAboutLaw
34 minutes
2 months ago
Hiring under pressure: the reform that could rewrite recruitment | Commercial Awareness Compass #46
The Employment Rights Bill would reshape unfair dismissal by reducing the current two-year qualifying period and introducing an “initial period of employment” that functions like a statutory probation. The headline proposal is unfair dismissal protection from day one, although recent parliamentary debate has floated alternatives such as a shorter qualifying period (e.g., six months). How might a statutory probation affect hiring and exit practices? Could tribunals handle a likely rise in clai...
The Commercial Awareness Compass by AllAboutLaw
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...